Related Experiment Video
Updated: Apr 9, 2026
10:49
Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
Published on: June 16, 2022
3.1K
Heat and Heal: Microwave-Responsive Gelling Hydrogel Nanocomposites for Postablation Extracellular Matrix
Yuting Cao1,2,3, Xinyu Zhong4, Qing Li5
1Department of Ultrasound Diagnosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
ACS Applied Materials & Interfaces
|April 8, 2026
Summary
This study introduces a novel microwave-responsive hydrogel to improve microwave ablation (MWA) therapy. The hydrogel enhances MWA heating and remodels the tumor microenvironment, boosting chemotherapy effectiveness and reducing recurrence.
Area of Science:
- Biomaterials Science
- Oncology
- Nanotechnology
Background:
- Microwave ablation (MWA) is a minimally invasive tumor therapy.
- Incomplete MWA can lead to tumor recurrence and metastasis.
- MWA-induced tissue changes can limit chemotherapy efficacy by hindering drug penetration.
Purpose of the Study:
- To develop a microwave-responsive gelling hydrogel nanocomposite.
- To enhance MWA heating and remodel the postablation microenvironment.
- To improve chemotherapeutic efficacy and reduce tumor recurrence after MWA.
Main Methods:
- Preparation of a nanocomposite with polymeric nanoparticles (CaCl2-rich core, tranilast-loaded shell) in alginate solution.
- Utilizing microwave irradiation to trigger nanoparticle rupture, calcium ion release, and in situ hydrogel formation.
- Evaluating the hydrogel's ability to enhance MWA heating and modulate the tumor microenvironment.
Main Results:
- The nanocomposite demonstrated microwave-responsive gelling behavior.
- In situ hydrogel formation via calcium cross-linking of alginate was achieved.
- The strategy showed potential for resolving insufficient heating and aberrant ECM remodeling.
Conclusions:
- The developed hydrogel nanocomposite offers a dual approach to enhance MWA therapy.
- It improves local tumor ablation and reduces postablation recurrence.
- This biocompatible platform presents a rational strategy for improving cancer treatment outcomes.
